Showing results (71-80 of 106) with videos related to
Sort By:
Pageof 11
Scientific Reports|May 15, 2021
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originatorLinda Cingolani, Brigida Barberio, Fabiana Zingone, et al.Digestive Diseases and Sciences|November 23, 2019
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative ColitisLorenzo Bertani, Giorgia Bodini, Maria Gloria Mumolo, et al.Rheumatology International|August 5, 2023
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective studyYlenia Marten Canavesio, Andrea Pasta, Francesco Calabrese, et al.Biomedicines|July 27, 2022
Adalimumab Biosimilar GP2017 versus Adalimumab Originator in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational StudyGiammarco Mocci, Giorgia Bodini, Leonardo Allegretta, et al.Nutrients|July 27, 2022
Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement DoseElisa Marabotto, Diego Ferone, Afscin Djahandideh Sheijani, et al.Therapeutic Advances in Gastroenterology|August 5, 2021
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian studyBrigida Barberio, Linda Cingolani, Cristina Canova, et al.Inflammatory Bowel Diseases|April 2, 2020
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte RatioLorenzo Bertani, Federico Rossari, Brigida Barberio, et al.Alimentary Pharmacology & Therapeutics|March 6, 2024
Applying Lyon consensus criteria in the work-up of patients with extra-oesophageal symptoms - A multicentre retrospective studyFrancesco Calabrese, Andrea Pasta, Giorgia Bodini, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 10, 2017
Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD studyMarco Daperno, Aurora Bortoli, Anna Kohn, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 18, 2026
Evaluation of the diagnostic accuracy of two esophageal biopsy sites compared to three in histological follow-up of eosinophilic esophagitis - A multicentric studyFrancesco Calabrese, Andrea Pasta, Manuele Furnari, et al.Pageof 11